VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+15.01%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$115M
AUM Growth
+$115M
(+45%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
28.25%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
267
New
23
Increased
109
Reduced
60
Closed
21
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.4M |
| 2 |
Geron
GERN
|
$870K |
| 3 |
Iovance Biotherapeutics
IOVA
|
$856K |
| 4 |
iShares MSCI India ETF
INDA
|
$838K |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$759K |
Top Sells
| 1 |
ProShares Ultra Utilities
UPW
|
$1.12M |
| 2 |
Vanguard Energy ETF
VDE
|
$721K |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$612K |
| 4 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
$421K |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$359K |
Sector Composition
| 1 | Healthcare | 78.8% |
| 2 | Financials | 0.81% |
| 3 | Technology | 0.52% |
| 4 | Consumer Discretionary | 0.44% |
| 5 | Communication Services | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
76
DELISTED
Audentes Therapeutics, Inc
BOLD
| $785K | 0.68% |
26,118
+14,220
| +120% | +$427K |
|
77
Ionis Pharmaceuticals
IONS
$9.64B
| $775K | 0.67% |
17,582
-1,028
| -6% | -$45.3K |
|
78
Biogen
BIIB
$20.8B
| $774K | 0.67% |
2,826
-164
| -5% | -$44.9K |
|
79
Lexicon Pharmaceuticals
LXRX
$392M
| $770K | 0.67% |
89,845
-5,234
| -6% | -$44.9K |
|
|
SAGE
80
DELISTED
Sage Therapeutics
SAGE
| $768K | 0.67% |
4,771
+2,584
| +118% | +$416K |
|
81
Exelixis
EXEL
$9.95B
| $764K | 0.66% |
34,479
-2,043
| -6% | -$45.3K |
|
|
ATNX
82
DELISTED
Athenex, Inc. Common Stock
ATNX
| $759K | 0.66% |
2,230
+1,183
| +113% | +$403K |
|
|
CBIO
83
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $755K | 0.66% |
465
+255
| +121% | +$414K |
|
84
Rigel Pharmaceuticals
RIGL
$710M
| $754K | 0.65% |
21,288
+11,415
| +116% | +$404K |
|
85
United Therapeutics
UTHR
$17.7B
| $754K | 0.65% |
6,708
-390
| -5% | -$43.8K |
|
86
Prothena Corp
PRTA
$452M
| $751K | 0.65% |
20,456
+10,904
| +114% | +$400K |
|
|
CLVS
87
DELISTED
Clovis Oncology, Inc.
CLVS
| $745K | 0.65% |
14,103
-826
| -6% | -$43.6K |
|
|
CELG
88
DELISTED
Celgene Corp
CELG
| $742K | 0.64% |
8,314
-491
| -6% | -$43.8K |
|
89
BioCryst Pharmaceuticals
BCRX
$1.74B
| $735K | 0.64% |
154,147
+83,066
| +117% | +$396K |
|
|
TVRD
90
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $735K | 0.64% |
1,649
+881
| +115% | +$393K |
|
91
Alnylam Pharmaceuticals
ALNY
$58.6B
| $721K | 0.63% |
6,052
+3,277
| +118% | +$390K |
|
|
BLUE
92
DELISTED
bluebird bio
BLUE
| $709K | 0.62% |
321
+171
| +114% | +$378K |
|
|
ACGN
93
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $708K | 0.61% |
2,833
+1,506
| +113% | +$376K |
|
|
AIMT
94
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $703K | 0.61% |
22,101
+11,765
| +114% | +$374K |
|
95
Alaunos Therapeutics
TCRT
$4.43M
| $695K | 0.6% |
1,183
+638
| +117% | +$375K |
|
96
Abeona Therapeutics
ABEO
$356M
| $677K | 0.59% |
1,886
+1,012
| +116% | +$363K |
|
97
Cytokinetics
CYTK
$5.98B
| $672K | 0.58% |
93,309
+50,664
| +119% | +$365K |
|
|
LUMO
98
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $656K | 0.57% |
10,061
+5,453
| +118% | +$356K |
|
|
TSRO
99
DELISTED
TESARO, Inc.
TSRO
| $651K | 0.56% |
11,391
-632
| -5% | -$36.1K |
|
|
DOVA
100
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $630K | 0.55% |
23,227
+12,183
| +110% | +$330K |
|